Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1173313/000121390021015729/f10k2020_americanbrivi.htm
November 2023
November 2023
November 2023
September 2023
August 2023
August 2023
August 2023
August 2023
July 2023
July 2023
Document and Entity Information - USD ($) | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2020 | Mar. 15, 2021 | Jun. 30, 2020 | |
Document and Entity Information [Abstract] | |||
Entity Registrant Name | American BriVision (Holding) Corp | ||
Entity Central Index Key | 0001173313 | ||
Amendment Flag | false | ||
Current Fiscal Year End Date | --12-31 | ||
Document Type | 10-K | ||
Document Period End Date | Dec. 31, 2020 | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2020 | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | true | ||
Entity Shell Company | false | ||
Entity Current Reporting Status | Yes | ||
Entity Emerging Growth Company | false | ||
Entity Filer Number | 333-91436 | ||
Entity Interactive Data Current | Yes | ||
Entity Incorporation State Country Code | NV | ||
Entity Common Stock, Shares Outstanding | 24,420,526 | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Public Float | $ 73,261,578 |
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1173313/000121390021015729/f10k2020_americanbrivi.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by American Brivision.
American Brivision's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
American Brivision provided additional information to their SEC Filing as exhibits
Ticker: ABVC
CIK: 1173313
Form Type: 10-K Annual Report
Accession Number: 0001213900-21-015729
Submitted to the SEC: Tue Mar 16 2021 4:30:59 PM EST
Accepted by the SEC: Tue Mar 16 2021
Period: Thursday, December 31, 2020
Industry: Pharmaceutical Preparations